Bisphenol A in Odontology: recent data by Vautherin, Thomas & Cardoso, Inês Lopes
Research Article   
Clinical Research and Trials
Clin Res Trials, 2019        doi: 10.15761/CRT.1000277
ISSN: 2059-0377
 Volume 5: 1-6
Bisphenol A in Odontology: Recent data
Vautherin T and Lopes Cardoso I*
Health Sciences Faculty, University Fernando Pessoa, Porto, Portugal
Abstract
Background and Objective: Bisphenol A (BPA) is an organic compound of the aromatic family used mainly as a monomer, for more than 50 years in the production 
of polycarbonate plastics and epoxy resins. Nowadays, bisphenol A is a worrying substance that deserves special attention. The goal of this work is to focus on 
bisphenol A and its biological effects on the human body. 
Methods: A bibliographic search was performed in databases such as PubMed, b-On and Elsevier. The keywords used were: "Bisphenol A", "BPA", "Endocrin 
Disruptor Chemicals".
Results: There are several known effects on the human body resulting from the exposure to BPA such as in the reproductive system, dentition, brain, behavior, 
cardiovascular and in immune systems. In the oral cavity, dental composites release bis-GMA and BPA immediately after placement but released doses are usually 
too low to lead to biological effects.
Conclusion: There are other materials such as silorans, Ormocer® and ionomer glass cements that can be good alternatives. Clinical studies are still neaded to prove 
that these materials are better than the composites, being these ones still the most used materials in conservative dental medicine.
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Introduction
Bisphenol A (BPA) is an organic compound belonging to the 
aromatic family used for more than 50 years, mainly as a monomer, 
in the production of polycarbonate plastics and epoxy resins. 
Polycarbonates are included in many everyday objects such as plastic 
baby bottles or bottles. On the other hand, epoxy resins are mainly 
found in the inner coating of cans and in composite resins.
For some years now, there has been much controversy regarding 
the biological effects of BPA. The first harmful effects of BPA use, were 
first observed in 1987 by Anna Soto and Carlos Sonnenschein in an 
experiment with tumor cell inhibitors. This study raised the possible 
role of BPA as a tumor cell initiator [1]. Its role as an endocrine 
disrupter had long been demonstrated [2]. However, recent studies 
have shown that the effects of BPA are not only hormonal but of 
various kinds. As a result, doubts about the effects of BPA led Canada 
to ban BPA bottles on 18th October 2008. Since 2011, by European 
Union directive, the use of BPA has been prohibited in baby products. 
In 2017, the European Chemicals Agency (ECHA) classified BPA as a 
“matter of utmost concern”.
With regard to dentistry, the problem focuses on composite resins 
as they are made from BPA. In addition, the aesthetic expectations of 
patients have been increasing and consequently the use of composite resins 
as well. What materials will replace composite resins in the future?
The aim of this work is to focus on bisphenol A in chemical and 
biological terms, as well as the legislation on its use. Next, the biological 
effects on the human body will be addressed. Finally, the influence 
of BPA on composite resins and other materials will be analyzed to 
evaluate possible alternatives.
A bibliographic search was performed in databases such as 
PubMed, b-On and Elsevier. The keywords used were: "Bisphenol A", 
"BPA", "Endocrin Disruptor Chemicals". The scientific articles and 
bibliographic reviews found were chosen from 2005 to 2019. Articles 
prior to this period were also chosen for their historical importance 
and relevance to the study. The exclusion criteria used were as follows: 
article whose scientific rigor would not have relevance or interest for 
the accomplishment of the work. Inclusion criteria were articles written 
in English, Portuguese or French. A total of 45 papers, books and web 
pages were selected with information considered relevant to this work.
Bisphenol A
Chemical structure
BPA has the chemical formula C15H16O2, being also called 
4,4'-(propane-2-ylidene) diphenol or p, p'-isopropylidenebisphenol. 
This compound was first synthesized in 1891 by the Russian chemist 
Alexandre Dianine [3].
BPA is a white solid presented as a powder or crystals. It consists of 
two aromatic rings linked together by a carbon bridge. This molecule 
is industrially synthesized from phenol and acetone by a condensation 
reaction catalyzed by a strong acid (usually hydrochloric acid) in the 
laboratory by a polystyrene base or resin (Figure 1).
BPA applications
BPA is mainly used as a monomer in the manufacture of 
polycarbonate plastic and epoxy resins. Polycarbonates are widely used 
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Mechanism of action and elimination
BPA's main gateway into the body is through absorption after 
ingestion of contaminated food. However, BPA may enter via other 
routes such as absorption by the sublingual mucosa, by the skin after 
contact with the drug or by the lungs through contaminated air.
Historically, BPA is a synthetic estrogen and therefore has 
estrogenic power. This agent will act on estrogen receptors ERα and Erβ 
as an agonist or antagonist depending on the situation [9]. However, its 
affinity for binding to those receptors is poor [10]. For this reason, it 
can be thought that the effects of BPA are negligible, however it can act 
on other receptors and produce more effects.
BPA can act on nuclear receptors - genomic pathway. BPA has 
been shown to have an effect on androgen [11], progesterone [11], 
pregnane X receptors [12], and LXR (liver X receptor) [3]. After BPA-
receptor binding, this receptor becomes active triggering diverse 
changes. For example, androgen receptors play a very important role 
in physiological processes such as male embryo development and 
differentiation, spermatogenesis, endocrine system or mammary 
gland development in women [11]. LXR is implicated in this process 
but also in brain function, skin development, immunity and glucose 
homeostasis [3].
Moreover, BPA can act in the non-genomic pathway. This is much 
faster than the genomic pathway and can function in parallel [13]. This 
substance allows signal transduction by activation of receptors located 
in the plasma membrane, causing a high level of signal amplification, 
that is: a low concentration of this molecule activates this pathway 
and induces important modifications such as cell proliferation and 
differentiation or apoptosis [13]. The signaling mechanism involves 
movement of ions (calcium, potassium, sodium and hydrogen) that 
will trigger the cellular response. For example, BPA may cause calcium 
flux-induced prolactin secretion [14].
BPA acts on nuclear receptors by disrupting the action and 
regulation of hormones, such as progesterone and estrogens, by altering 
their synthesis, activity and inhibition mechanism [15]. It also disturbs 
the pituitary and thyroid hormones (T3 and T4) [16], androgens [16] 
and testosterone.
The major route of elimination of BPA involves its conjugation 
with glucuronic acid to BPA-glucuronide (BPA-G) which occurs 
mainly in the liver and to a lesser extent in the intestine. This reaction is 
catalyzed by the enzyme glucuronyltransferase, called UGT2B1 in rats 
while in humans there are two isoforms UGT2B15 and UGT2B7 [17]. 
In humans, the plasma peak of BPA-G is at 80 minutes, and its plasma 
concentration decreases exponentially with a half-life of 89 minutes 
[18]. A small part of BPA is conjugated with sulphate (BPA-S).
BPA-G and BPA-S represent the forms of elimination of BPA 
since these molecules are not capable of binding to estrogen receptors. 
However, deconugation may occur at some specific sites by the enzymes 
β-glucuronidase and arylsulfatase C, and BPA is free and active and 
may act on estrogen receptors again [19].
Effects of bisphenol exposure
Studying the effects of BPA on the human population is not 
easy, as for ethical reasons it is not possible to directly test the effect 
of BPA on humans. For this reason, studies in the human population 
are epidemiological, determining the concentrations of BPA to which 
individuals were exposed and comparing with observed pathologies. 
It is not possible to establish a causal relationship, but only to draw 
probabilistic conclusions.
Figure 1. Reaction of bisphenol A synthesis
in everyday products such as sunglasses, CDs and food containers. In 
the late twentieth century, it is abundantly present in receipts (thermal 
paper). Some monomers are part of composite resins. BPA gives high 
resistance to heat and shock to plastics and is therefore widely used in 
construction and in the automobile industry.
Dose/Effect and Legislation
Bisphenol A is nowadays a matter of concern and therefore deserves 
special attention. The European Food Safety Authority (EFSA) issues a 
science-based warning to risk managers regarding BPA's safety when 
used in materials of food containers. EFSA establishes an Acceptable 
Daily Intake (ADI) which is the dose that can be taken daily for a lifetime 
without health risks. This is expressed in milligrams or micrograms per 
kilogram body weight per day (mg/kg bw/day). In 2006, EFSA set the 
ADI at 0.05 mg/kg bw/day. This daily dose was calculated from the 
lowest dose required for development of an effect (50 mg/kg bw/day; 
LOAEL - Low Observed Adverse Effect Level) [4]. For the calculation 
of the daily allowable dose, without causing adverse effects, a factor 
of 1000 was chosen, obtaining the dose of 50 µg/kg bw/day, which is 
called NOAEL (No Observed Adverse Effect Level) [4]. In 2008, EFSA, 
concerned about the ability of babies and adults to eliminate BPA from 
the body, stated that BPA exposure should be much lower than ADI 
exposure. Children and adults are able to metabolize and eliminate this 
substance at rates much higher than DDT. In 2015, EFSA's in-depth 
assessment of BPA exposure and toxicity concluded that bisphenol 
A does not pose a risk to consumers (including newborns, infants, 
children and adolescents) at current exposure levels. Moreover, the 
ADI was changed to 0.4 µg/kg bw/day [5].
It has long been thought that the dose provokes the effect, that 
is, the higher the dose, the greater the effect. However, several years 
ago, some studies showed a nonlinear U-shape curve in the dose-
effect relationship of BPA exposure [6]. This means that the effects are 
significant for low doses, decrease with increasing BPA, and increase 
again for high doses of this compound [6].
BPA as an endocrine disruptor
The endocrine system is one of the body's regulatory systems that 
works synergistically with the nervous system. This system consists 
of endocrine glands (pituitary, epiphysis, thyroid, parathyroid and 
adrenal) and endocrine cells present in organs with other functions 
(pancreas, gonads, kidneys and hypothalamus). Its main role is 
the maintenance of homeostasis and adaptation to the external 
environment: electrolyte and glucose balance, growth, lactation, 
hematopoiesis through the secretion of hormones into the blood (such 
as growth hormone, prolactin and insulin).
According to the World Health Organization (WHO), an endocrine 
disruptor is an exogenous substance or mixture of substances capable 
of inducing endocrine disruption in an intact organism, its descendants 
or subpopulations [7]. An Endocrin Disruptor Chemical (EDC) is an 
exogenous chemical or mixture of chemicals, that can interfere with 
any aspect of hormonal action. To assess the potential of EDC in the 
development of deleterious effects, consideration should be given to 
the regulation of its synthesis, secretion and hormonal actions, and the 
variation in regulation of these events throughout the life cycle [8].
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For these reasons, animal studies have been performed, although 
their pathophysiology is different from that of humans, and the 
results cannot be directly extrapolated. In addition, BPA is universally 
widespread and therefore difficult to have control groups of individuals 
not exposed to this molecule [20].
There are several known effects on human organism from exposure 
to BPA but it is also of great concern the possibility of absorption of 
this compound by the fetus since the embryonic period is critical in 
the development of the fetus. Several studies have shown the presence 
of BPA in the fetus and amniotic fluid [21]. Thus, BPA is capable of 
crossing the placenta [21]. Moreover, in the fetus / embryo the liver is still 
immature and therefore BPA metabolism is lower than in adults [21].
Reproductive system
BPA has been found to alter the synthesis and metabolism of 
endogenous hormones and estrogen α and β receptors [22].
In men, BPA has harmful effects on the male reproductive system, 
disturbing its development and may even modify its structure. This 
compound is also toxic to the testicles, decreasing fertility by reducing 
sperm production, quality and mobility and increasing prostate 
size [23]. These changes result from the fact that gametogenesis and 
steroidogenesis are sensitive to estrogens.
BPA also structurally modifies the female reproductive tract. 
It leads to a decrease in ovarian and uterine weight, increases the 
occurrence of ovarian cysts and endometrial hyperplasias. The vagina 
also has a weight reduction, an increase in the endometrium lamina 
propria and endometrium estrogen and progesterone receptors [23].
Al-Hiyasat, et al. [24] were interested in the consequences of bis-
GMA release on rat fertility. This study showed a strong decrease in 
fertility in male rats, with reduced sperm count and reduced fertility 
rate in females who were in contact with males exposed to bis-GMA. 
These authors state that bis-GMA has a reprotoxic effect [24]. However, 
the doses of bis-GMA released by the composites are too low to induce 
such changes in humans.
Dentition
Exposure to BPA leads to molar incisor hypomineralization (MIH). 
It is a structural failure of the enamel, at least in a permanent first molar 
or not associated with other teeth (in most cases with an incisor). This 
change is characterized by porous hypomineralized enamel, with the 
appearance of white or yellowish / brown spots and more sensitive to 
fracture. This is a defect in the quality of enamel [25].
Studies have been conducted to assess the impact of BPA exposure 
on teeth. An increase in albumin, an increase in mRNA encoding 
enamelin and consequently in this protein, and a decrease in kallikrein 
4 (KLK4) mRNA, a protease that degrades enamel proteins during the 
maturation phase [26], has been observed.
In addition, studies in rats treated for 100 days with BPA showed 
that they had normal erupting enamel while rats treated for 30 days 
had MIH-like enamel hypomineralizations [27]. This means that 
amelogenesis is only sensitive to MIH causative agents during a 
developmental exposure window. Thus, in humans this critical window 
would be between birth and 5 months of age because it corresponds 
to the mineralization period of the affected teeth in cases of MIH 
(incisors and first molars). This is supported by the fact that during 
this period the newborn is particularly sensitive to BPA due to its 
immature liver [27].
Thus, MIH can function as a marker for cases of early exposure 
to BPA [27]. In another study by the same authors, BPA has been 
shown to have more effect alone than associated with other endocrine 
disruptors such as genistein and vinclozoline [28].
Brain
Since BPA can cross the blood-brain barrier, exposure to BPA 
has been shown to be associated with multiple neuropsychological 
disorders and neurobehavioral disorders. The mechanism of action is 
still uncertain.
Studies using human cortical neurons (hCN) derived from human 
embryonic stem cells as a cellular model have been performed to study 
the undesirable neurotoxic effects of BPA [29]. The results revealed that 
chronic exposure to BPA impairs neural morphology, induces neuronal 
apoptosis and decreases MAP2 gene expression (neural marker) [29]. 
After exposure to BPA, intracellular calcium levels were elevated 
[29]. Therefore, BPA appears to have neurotoxic effects on these cells, 
causing apoptosis that may result from a disturbance of intracellular 
calcium homeostasis and consequent cellular dysfunction [29].
It is further described that BPA can increase aggressiveness [30], 
hyperactivity [31], anxiety [32], increase the risk of depression and 
learning disabilities [31].
This compound may also diminish the parental and social 
relationship. Animals exposed to BPA are found to care less for their 
young and play less [33].
Cardiovascular system
Many studies have been done to evaluate the relationship between 
BPA concentration and the risk of heart disease. In fact, in different 
patient groups, an increase in BPA concentration is associated with 
hypertension [34], decreased heart rate [34], peripheral arterial 
problems, and changes in the expression of genes involved in the 
pathophysiology of the heart.
Immune system
It has been observed that BPA appears to have proinflammatory 
activity, increasing some inflammation mediators such as TNF-α, IL-8 
and IL-13, and decreasing the number of macrophages [35]. EFSA 
claims to have new data on the effect of BPA on the immune system 
of animals, however there is insufficient evidence to draw conclusions 
about the effect on humans [36].
Bisphenol A in composite resins and other materials
Composite resins
The aesthetic and electrochemical problems of silver amalgams and 
the lack of biocompatibility of silicates and polymethyl methacrylates 
(PMMA) led to the development of a new material in the 1960s: 
composite resins.
Composite resins consist of organic matrix, filler particles and 
silane.
The organic matrix represents between 30 and 50% of the total 
volume and allows to have a plastic material before polymerization 
and hard after polymerization. In addition, the die ensures cohesion 
with the other elements and protects the structure against abrasion and 
chemical or mechanical aggression. The most commonly used matrix 
is bisphenol A-glycidyl methacrylate (bis-GMA or Bowen matrix). In 
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addition, it is also found in diluents and viscosity controllers such as 
bisphenol A dimethacrylate (bis-DMA).
The mineral particles of inorganic charge, are linked to the organic 
matrix through silane and allow to increase the mechanical properties 
such as tensile strength, bending and compression and radio opacity. 
They also compensate for the coefficient of thermal expansion that is 
too high in the matrix phase.
Silane, a bipolar organo-mineral molecule, that ensures cohesion 
between mineral fillers and the organic matrix. This silane binds to the 
hydroxide groups of the fillers and polymerizes with the monomer to 
form a covalent bond.
Composite resins when placed in the mouth will be subject to 
temperature fluctuations, mechanical forces resulting from chewing 
or even saliva that is in permanent contact with the composite. Some 
researchers have shown that saliva contains cholesterol esterases that 
can hydrolyze bis-GMA molecules [37]. Other authors report that 
salivary esterases may cleave the ester binding of bis-DMA molecules, 
leading to BPA release [38]. The potential release of BPA from the 
composites used was studied to maintain retention after orthodontic 
treatment. These studies showed that there is a sharp increase in BPA 
levels in saliva 1 hour after exposure to BPA, the next day the samples 
already show BPA levels similar to the control. Thus, BPA release is 
significant within the first minutes or hours after composite placement 
[39].
Other studies have attempted to assess the consequences of BPA 
release by analyzing the effects of bis-GMA on human lymphocyte 
DNA [40]. The results showed that bis-GMA can damage DNA even 
leading to breaks in its double strand. These DNA lesions are found to 
be irreversible [40].
The degree of toxicity also varies with the type of composite. Flow 
composites have less charge and therefore more monomers. Both 
conventional and Flow composites will release bis-GMA, TEGDMA, 
UDMA and even BPA, however there is greater cytotoxicity in Flow 
composites compared to conventional ones [24].
Moreover, also the time used in composite polymerization appears 
to affect the release of BPA and therefore its toxicity. This curing time 
may vary between 20 and 40 seconds depending on the manufacturer. 
Studies have shown that a 40 second polymerization is insufficient to 
prevent the release of many monomers [41]. In fact, oxygen from air 
is a polymerization inhibitor of composites. Monomer free radicals 
react with oxygen in the air affecting polymerization, with only a 
thin layer of bis-GMA oligomers (50-100µm) forming on the surface 
of the composites. Therefore, unpolymerized monomers are left that 
will release BPA molecules into the oral cavity in the short term. It is 
therefore very important to follow the manufacturer's polymerization 
instructions.
Alternative materials 
Several researches have been conducted to change the composition 
of composites and especially the load. To this end, these studies 
attempt to modify the composition of composites by introducing 
glass fibers, titanium dioxide nanoparticles, calcium fluorides or even 
antimicrobial agents [42,43].
It is known that it is mainly free monomers present in the organic 
matrix that are most likely to cause cellular damage. For this reason, 
researchers have tried to incorporate new monomers into resins. These 
include many methacrylate derivatives, as well as new families, many 
of which are still experimental, such as epoxy resins, oxiranes/sylorans 
or spiro-ortho-carbonates (SOC) (Table 1).
Sylorans  : 3M ESPE sells a silorane-based composite resin (a 
molecule obtained by combining a siloxane and an oxirane) whose 
polymerization process is quite different from that of other composite 
families. This composite does not have BPA in its composition, but 
the adhesive "Silorane System Adhesive Self-Etch" has BPA in its pure 
form [44]. This composite is preferably used in Class I and II posterior 
tooth restorations. Although oxiranes are known to be biocompatible 
and siloranes are non-toxic, there are still few public health studies 
regarding the biocompatibility of composite resins and therefore 
dentists often do not use these new monomers.
Ormocer ® : The main cause of failure of composite resin coatings 
comes from resin volume variations over time. In order to limit this 
disadvantage, new matrices such as the Ormocer matrices have been 
developed. This term is short for «Organically Modified Ceramics».
These matrices contain polymers derived from the addition of 
small monomer units whose nucleus consists essentially of silicon 
atoms associated with silanized inorganic fillers. Polysiloxane chains 
formed by the silicon and oxygen chain are associated with other 
chains that react during polymerization and contribute to an organic 
functionalization of the initially formed network.
Ormocers matrices combine properties of silicone, polymer 
hardness and thermal stability of ceramics. Compared to conventional 
composites, Ormocer®-based dental materials have greater 
biocompatibility, less polymerization shrinkage and fewer residual 
monomers. It also has good abrasion resistance.
All of these characteristics that these organic-inorganic hybrid 
polymers possess seem to be very interesting in conservative dentistry. 
However, in this technology used in the Admira range, developed by 
VOCO (manufacturer), the inorganic part consists of Bis-GMA.
Studies have shown that Ormocer® matrices have properties superior 
to those of a standard hybrid composite and better polymerization, 
consequently having fewer residual monomers [45]. However, clinical 
confirmation is still lacking, and other studies are needed to be able to 
state that Ormocer® is a better product than conventional composites. 
Clinical studies with Ormocer® showed no significant differences from 
conventional composites [46] (Table 2).
Family of monomers Monomers in comercialized products Experimental monomers




Epoxy resins - Imino ethylene
Oxiranes/Sylorans Sylorans Oxiranes
SOC -
Table 1. Monomers classification [43]
Mechanical properties Hybrid composite Ormocer
Polimerization Low High
Residual free monomers High Low
Hardening Low High
Flexural strength Low High
Compressive strength High Low
Marginal adaptation Low High
Table 2. Comparison of properties of hybrid composites and composites based on 
Ormocer® [45]
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Ionomer Glass Cements (IGC): IGC allow the replacement of 
silicates used in previous sectors that have several disadvantages 
(low biocompatibility, high coefficient of thermal expansion, poor 
mechanical properties).
IGCs consist of a powder, an aluminum fluorine silicate, and a 
liquid, an aqueous solution acidifyed with maleic acid, a tricarboxylic 
acid used to control viscosity [47]. They have low mechanical properties 
and therefore, are not indicated in cases of restoration in sectors with 
many occlusal loads and cannot be used as a definitive material.
There are also Resin Addition Modified Ionomer Glass Cements. 
The incorporated resin particles are molecules like HEMA, bis-GMA 
that will increase their mechanical properties, however BPA is again 
present.
Discussion
Several biological effects of bisphenol A are now known. Several 
studies have raised concerns that this molecule may, in addition to 
other effects, cause hormonal disorders. Effects on other organs such 
as the brain, cardiovascular system, immune system, thyroid and 
reproductive system were also highlighted.
Recently, a relationship between exposure to BPA and incisor-
molar hypomineralization has been discovered. In response to this 
finding, steps have already been taken, particularly in the European 
Union, to limit the presence of BPA, especially in the agri-food sector, 
where its use is widespread.
Regarding dental composites, studies have shown that BPA is 
released after placement in the oral cavity. However, the released doses 
are low and can only be detected within hours of the application of the 
composites.
A direct link between BPA and changes in organism has not been 
demonstrated yet, but suspicions remain. Therefore, further studies, 
especially in humans, are needed to extrapolate experimental data to 
clinical practice.
Conclusion
The challenges for patients, dentists and the industry, are great. 
Indeed, the NINAMATA convention held in Geneva in January 2013 
recommended, for environmental protection, a reduction in the use of 
amalgam without, for the time being, banning its use.
It has been found that the use of amalgam has been declining for 
several years, being replaced by composites. However, recent data 
on bisphenol A present in dental composites have cast doubt on the 
consequences it may have.
Currently, manufacturers are not yet able to provide a satisfactory 
material to replace composites. The BPA replacement molecule has not 
yet been discovered.
Even though there are some other products that can be used for 
preservative care for some years, such as Glass Ionomer Cements or 
Ormocer®, they do not always meet the therapeutic requirements.
Research on new molecules remains an extremely important 
challenge, which should lead to the development of perfectly 
biocompatible new materials in the coming years.
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